Showing 1 - 12 results of 12 for search 'Gordon L. Amidon', query time: 0.04s Refine Results
  1. 1
    Selection of Suitable Prodrug Candidates for in vivo Studies via in vitro Studies; The Correlation of Prodrug Stability in Between Cell Culture Homogenates and Human Tissue Homogenates

    Selection of Suitable Prodrug Candidates for in vivo Studies via in vitro Studies; The Correlation of Prodrug Stability in Between Cell Culture Homogenates and Human Tissue Homogen... by Yasuhiro Tsume, Gordon L Amidon

    Published 2012-07-01
    Get full text
    Article
  2. 2
    The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs

    The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs by Yasuhiro Tsume, Blanca Borras Bermejo, Gordon L. Amidon

    Published 2014-01-01
    Get full text
    Article
  3. 3
    An improved synthesis of a fluorophosphonate–polyethylene glycol–biotin probe and its use against competitive substrates

    An improved synthesis of a fluorophosphonate–polyethylene glycol–biotin probe and its use against competitive substrates by Hao Xu, Hairat Sabit, Gordon L. Amidon, H. D. Hollis Showalter

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine

    Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine by Yasuhiro Tsume, Adam J. Drelich, David E. Smith, Gordon L. Amidon

    Published 2017-08-01
    Get full text
    Article
  5. 5
    Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola<sup>®</sup> on the Luminal and Systemic Behavior of Loratadine (BCS Class 2b)

    Application of the Gastrointestinal Simulator (GIS) Coupled with In Silico Modeling to Measure the Impact of Coca-Cola<sup>®</sup> on the Luminal and Systemic Behavior of Loratadin... by Bart Hens, Marival Bermejo, Patrick Augustijns, Rodrigo Cristofoletti, Gregory E. Amidon, Gordon L. Amidon

    Published 2020-06-01
    Get full text
    Article
  6. 6
    The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil

    The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil by Milica Markovic, Moran Zur, Sapir Garsiani, Daniel Porat, Sandra Cvijić, Gordon L. Amidon, Arik Dahan

    Published 2022-06-01
    Get full text
    Article
  7. 7
    Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters

    Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters by Gordon L. Amidon, Chandrasekharan Ramachandran, John M. Hilfinger, Christopher P. Landowski, Jing Sun, Balvinder S. Vig, Yasuhiro Tsume

    Published 2008-06-01
    Get full text
    Article
  8. 8
    A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP

    A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP by Marival Bermejo, Bart Hens, Joseph Dickens, Deanna Mudie, Paulo Paixão, Yasuhiro Tsume, Kerby Shedden, Gordon L. Amidon

    Published 2020-01-01
    Get full text
    Article
  9. 9
    Biphasic Dissolution as an Exploratory Method during Early Drug Product Development

    Biphasic Dissolution as an Exploratory Method during Early Drug Product Development by Daniela Amaral Silva, Jozef Al-Gousous, Neal M. Davies, Nadia Bou Chacra, Gregory K. Webster, Elke Lipka, Gordon L. Amidon, Raimar Löbenberg

    Published 2020-05-01
    Get full text
    Article
  10. 10
    An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products

    An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products by Isabel Gonzalez-Alvarez, Marival Bermejo, Yasuhiro Tsume, Alejandro Ruiz-Picazo, Marta Gonzalez-Alvarez, Bart Hens, Alfredo Garcia-Arieta, Greg E. Amidon, Gordon L. Amidon

    Published 2021-04-01
    Get full text
    Article
  11. 11
    Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses

    Exploring Bioequivalence of Dexketoprofen Trometamol Drug Products with the Gastrointestinal Simulator (GIS) and Precipitation Pathways Analyses by Marival Bermejo, Gislaine Kuminek, Jozef Al-Gousous, Alejandro Ruiz-Picazo, Yasuhiro Tsume, Alfredo Garcia-Arieta, Isabel González-Alvarez, Bart Hens, Gregory E. Amidon, Nair Rodriguez-Hornedo, Gordon L. Amidon, Deanna Mudie

    Published 2019-03-01
    Get full text
    Article
  12. 12
    Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants.

    Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomita... by Khaled Heissam, Nichola Abrehart, Caroline L Hoad, Jeff Wright, Alex Menys, Kathryn Murray, Paul M Glover, Geoffrey Hebbard, Penny A Gowland, Jason Baker, William L Hasler, Robin C Spiller, Maura Corsetti, James G Brasseur, Bart Hens, Kerby Shedden, Joseph Dickens, Deanna M Mudie, Greg E Amidon, Gordon L Amidon, Luca Marciani

    Published 2020-01-01
    Get full text
    Article

Search Tools: